Weekly Policy Blog: CBSA Advocates on Federal Issues During the BIO Fly-In
By: Colorado BioScience Association Date: 04/22/2024
Colorado Bioscience Association (CBSA) Vice President and Counsel for Policy + Advocacy, Amy Goodman, represented the Colorado life sciences ecosystem and advocated for community priorities on Capitol...
Learn MoreWeekly Policy Blog: Grants and Tax Credits Support Colorado’s Advanced Industries
By: Colorado BioScience Association Date: 04/08/2024
Two of the Capital + Growth programs supporting efforts to position Colorado as America’s epicenter for talent, investors, and life sciences-centric companies looking to start, relocate, or expand in...
Learn MoreCNBC Covers the Growth of Life Sciences in Colorado
By: Colorado BioScience Association Date: 04/08/2024
Story Emphasizes Record Investment, Top Talent, Innovative Research Collaborations, and Investments in Lab Space A glimpse inside the Center for Drug Discovery at CU Anschutz Medical Campus, led by Dr...
Learn MoreA talk with April Giles, Vice President of Business Development, Fitzsimons Innovation Community
By: Colorado BioScience Association Date: 04/01/2024
By: Fitzsimons Innovation Community The first time April Giles, Vice President of Business Development for Fitzsimons Innovation Community, spent real time on the University of Colorado School of Medi...
Learn MoreWeekly Policy Blog: Amgen Lawsuit Asserts Colorado PDAB is Unconstitutional
By: Colorado BioScience Association Date: 04/01/2024
On March 22, Amgen, the maker of the autoimmune disease drug Enbrel, filed a lawsuit against the Colorado Prescription Drug Affordability Board (PDAB or Board) in the U.S. District Court for the Distr...
Learn MoreWeekly Policy Blog: Colorado Drug Importation Program Faces Roadblocks
By: Colorado BioScience Association Date: 03/25/2024
Colorado is still working to become the second state, after Florida, to be authorized to import prescription drugs from Canada. The Colorado Department of Health Care Policy & Financing (HCPF) sub...
Learn MoreWeekly Policy Blog: EPA Releases Final Rule for EtO Sterilization Facilities
By: Colorado BioScience Association Date: 03/18/2024
On March 14, the Environmental Protection Agency (EPA) released its update to the National Emission Standards for Hazardous Air Pollutants (NESHAP) final rule for ethylene oxide (EtO) commercial steri...
Learn MoreColorado BioScience Association Appoints New Board of Directors Leaders from OrganiShield and General Inception
By: Colorado BioScience Association Date: 03/15/2024
For Immediate Release: March 19, 2024 Executives from Colorado State University, KBI Biopharma, Metro Denver Economic Development Corporation, Terumo Blood and Cell Technologies, and STAQ Pharma Join...
Learn MoreWeekly Policy Blog: Campaign & Legislation Support Colorado’s Drive to Be a Leading Life Sciences Hub
By: Colorado BioScience Association Date: 03/11/2024
Colorado BioScience Association and a consortium of 22 Colorado partners have launched Colorado Hub for Health Impact, a new national economic development campaign to position Colorado as America’s ep...
Learn MoreWeekly Policy Blog: CBSA’s 2024 Day at the Capitol
By: Colorado BioScience Association Date: 03/04/2024
CBSA held its annual Day at the Capitol event on February 28. CBSA members, legislators, and legislative staff first gathered for a health innovation company showcase and networking, which highlighted...
Learn More